SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 48 filers reported holding SCPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $72,000 | -33.3% | 9,547 | -35.3% | 0.00% | – |
| Q2 2020 | $108,000 | +42.1% | 14,755 | +42.6% | 0.00% | – |
| Q1 2020 | $76,000 | +49.0% | 10,347 | +16.5% | 0.00% | – |
| Q4 2019 | $51,000 | -3.8% | 8,884 | 0.0% | 0.00% | – |
| Q3 2019 | $53,000 | +278.6% | 8,884 | +96.4% | 0.00% | – |
| Q2 2019 | $14,000 | -89.3% | 4,523 | -87.0% | 0.00% | -100.0% |
| Q4 2018 | $131,000 | -36.1% | 34,841 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $205,000 | +21.3% | 34,841 | +16.9% | 0.00% | 0.0% |
| Q2 2018 | $169,000 | – | 29,815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,831,474 | $20,268,000 | 6.83% |
| AIGH Capital Management LLC | 637,322 | $3,372,000 | 1.37% |
| Worth Venture Partners, LLC | 162,875 | $862,000 | 0.68% |
| Ikarian Capital, LLC | 1,466,147 | $7,756,000 | 0.34% |
| RA Capital Management | 3,518,998 | $18,615,000 | 0.26% |
| Orbimed Advisors | 4,797,148 | $25,377,000 | 0.22% |
| DAFNA Capital Management LLC | 38,891 | $206,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 150,699 | $797,000 | 0.03% |
| Alyeska Investment Group, L.P. | 355,690 | $1,882,000 | 0.03% |
| ALGERT GLOBAL LLC | 13,860 | $73,000 | 0.02% |